logo
Plus   Neg
Share
Email

Bovie Medical Reveals That J-Plasma Performs Well In All Surgeries

Bovie Medical Corporation (BVX) Tuesday announced that its product J-Plasma has been performing well in both laparoscopic surgeries as well as open
surgeries.

The company, engaged in the manufacture and marketing of electrosurgical products, stated that in multiple patient procedures, there was a decrease in smoke, less charring and overall excellent tissue response when compared to current electrosurgery devices.

Jeff Rencher, Vice President of Sales and Marketing of Surgical Products stated, "The positive results achieved by J-Plasma met all expectations as we prepare to embark on an aggressive marketing program for the product."

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
In the age of social media, it takes mere hours for a company to suffer the backlash of of allegations of racism. For some companies, these incidents have hurt their bottom line and sullied their reputations. For others, they were a blip caused by clumsy if not altogether coincidental missteps. In... BJ's Wholesale Club Holdings Inc., which is planning a return to the public market, has set terms for its planned initial public offering or IPO. In a filing with the U.S. Securities and Exchange Commission, the warehouse club operator said Monday that it plans to offer 37.5 million shares priced between $15 and $17 per share. At the top end of the range, the offering would raise $637.5 million. Shares of Valeant Pharmaceuticals International Inc. are falling more than 6 percent in Monday's trading following news that the U.S. Food and Drug Administration has failed to approve the Canada-based company's Duobrii lotion for the treatment of plaque psoriasis. Ortho Dermatologics, a division of Valeant Pharmaceuticals, said it has received a Complete Response Letter or CRL from the FDA.
Follow RTT